What is Zantac? The U.S. Food and Drug Administration (FDA) announced on September 13, 2019, that low levels of N-nitrosodimethylamine (NDMA) were detected in Zantac. NDMA is a carcinogen, and was found in many drugs over the past few years. Most recently, high levels of NDMA were found in a...

The post Zantac: Heartburn Medication Recalled for Cancer-Causing Side Effects appeared first on .